EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Chemotherapy

Description
international journal of experimental and clinical chemotherapy

 

Status
active
Indexing
Current Contents/Life Sciences, Pubmed/MEDLINE, Excerpta Medica, Biological Abstracts, Chemical Abstracts.
Predecessor
Chemotherapia
Subject

Source type
Journal
Publisher
ISBN ISSN
0009-3157
E ISSN
1421-9794
First volume
13
Last volume
56+
Publish city
Basel
Homepage
Description
This journal publishes original research articles and state-of-the-art reviews on all aspects of antiinfective and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamic properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide. Regular supplement issues devoted to specific topics related to antibiotic and cytostatic chemotherapy provide an additional bonus for subscribers.











Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )